ArticleThe journal of allergy and clinical immunology. Global2023

JAK1 inhibition with abrocitinib decreases allergen-specific basophil and T-cell activation in pediatric peanut allergy.

Nicole Ramsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.